These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2190251)

  • 1. Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone.
    Sharma RP; Javaid JI; Pandey GN; Easton M; Davis JM
    Psychiatry Res; 1990 Apr; 32(1):9-17. PubMed ID: 2190251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.
    Sharma RP; Javaid JI; Pandey GN; Janicak PG; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):459-66. PubMed ID: 1657221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume.
    Breier A; Davis OR; Buchanan RW; Moricle LA; Munson RC
    Arch Gen Psychiatry; 1993 Jul; 50(7):541-50. PubMed ID: 8317948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of plasma HVA response to dexamethasone in psychotic depression.
    Wolkowitz OM; Doran A; Breier A; Roy A; Pickar D
    Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and CSF HVA before and after pharmacological treatment.
    Sharma R; Javaid JI; Janicak P; Faull K; Comaty J; Davis JM
    Psychiatry Res; 1989 Apr; 28(1):97-104. PubMed ID: 2740469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Biol Psychiatry; 1991 Sep; 30(5):475-82. PubMed ID: 1932395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotic patients with increased plasma HVA and MHPG or increased HVA alone.
    Bowers MB
    Biol Psychiatry; 1993 Oct; 34(8):584-6. PubMed ID: 8274591
    [No Abstract]   [Full Text] [Related]  

  • 10. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
    Konicki PE; Owen RR; Litman RE; Pickar D
    Life Sci; 1991; 48(14):1411-6. PubMed ID: 2008157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia.
    Lieberman JA; Alvir J; Geisler S; Ramos-Lorenzi J; Woerner M; Novacenko H; Cooper T; Kane JM
    Neuropsychopharmacology; 1994 Oct; 11(2):107-18. PubMed ID: 7840862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
    Amin F; Davidson M; Kahn RS; Schmeidler J; Stern R; Knott PJ; Apter S
    Schizophr Bull; 1995; 21(1):53-66. PubMed ID: 7770741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid.
    Labarca R; Silva H; Jerez S; Ruiz A; Forray MI; Gysling K; Andres ME; Bustos G; Castillo Y; Hono J
    Schizophr Res; 1993 Mar; 9(1):29-34. PubMed ID: 8461269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
    Dommisse CS; Schulz SC; Narasimhachari N; Blackard WG; Hamer RM
    Biol Psychiatry; 1984 Sep; 19(9):1305-15. PubMed ID: 6149772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methylphenidate on serum growth hormone: influence of antipsychotic drugs and diagnosis.
    Janowsky DS; Leichner P; Parker D; Judd L; Huey L; Clopton P
    Arch Gen Psychiatry; 1978 Nov; 35(11):1384-9. PubMed ID: 30430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man.
    Posener JA; Schatzberg AF; Williams GH; Samson JA; McHale NL; Bessette MP; Schildkraut JJ
    Biol Psychiatry; 1999 Jan; 45(2):222-8. PubMed ID: 9951570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period.
    Sharma RP; Javaid JI; Davis JM; Janicak PG
    Biol Psychiatry; 1998 Sep; 44(6):488-92. PubMed ID: 9777181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
    Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D
    Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma HVA, neuroleptics, and dopaminergic plasticity.
    Dávila R
    Biol Psychiatry; 1989 Jan; 25(1):1-3. PubMed ID: 2563229
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
    Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J
    Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.